Analyze Diet

Topic:Treatment

Treatments for horses encompasses a range of medical and therapeutic interventions aimed at maintaining or restoring equine health. This field involves the use of pharmaceuticals, surgical procedures, and alternative therapies to address various conditions affecting horses. Common treatments include the administration of anti-inflammatory drugs, antibiotics, and vaccines, as well as physical therapies and nutritional management. Research in this area focuses on evaluating the efficacy, safety, and outcomes of different treatment modalities. This page collects peer-reviewed research studies and scholarly articles that explore the methods, advancements, and clinical outcomes associated with equine treatment practices.
Controlling drug-resistant bacteria in Arabian horses: bacteriophage cocktails for treating wound infections.
Frontiers in veterinary science    October 15, 2025   Volume 12 1609955 doi: 10.3389/fvets.2025.1609955
Khalid E, Tartor YH, Ammar AM, Abdelaziz R, Mahmmod Y, Abdelkhalek A.Antimicrobial resistance is a major global health issue requiring a coordinated response. This study investigated for the first time the prevalence, antimicrobial resistance phenotypes of bacteria causing infections in Arabian horses, and the potential of bacteriophage therapy for wound treatment. One hundred clinical samples from infected Arabian horses, presenting respiratory disorders, diarrhea, abortion, wound, and ocular infection, were examined using direct sample multiplex PCR and phenotypic methods. Antimicrobial susceptibility testing of the recovered isolates was performed using pane...
Pharmacokinetic analysis of bumped-kinase inhibitors in horses demonstrates their potential utility for prevention and treatment of equine protozoal myeloencephalitis.
American journal of veterinary research    October 14, 2025   Volume 87, Issue 1 ajvr.25.07.0270 doi: 10.2460/ajvr.25.07.0270
Rocha IA, McPeek JL, Hulverson MA, Choi R, Orr K, Sponseller BT, Kennedy T, Ojo KK, Barrett LK, Ruby R, Janes J, Reed SM, Arnold SLM, Van Voorhis WC....To determine the systemic and CNS distribution of bumped-kinase inhibitors (BKIs) in healthy horses, assess potential side effects, and identify a candidate compound for a clinical trial in equine protozoal myeloencephalitis (EPM) cases. Unassigned: 9 pharmacokinetic (PK) experiments were conducted from March 2021 through November 2024. Bumped-kinase inhibitors 1708, 1748, and 1841 were screened in Sarcocystis neurona growth assays and IV PKs, followed by investigation of a lead BKI compound by single-dose or multiday oral administration. Serial plasma collections were performed to assess syst...
A Multi-Site Observational Evaluation of the Equine Assisted Growth and Learning Association Model of Equine-Assisted Psychotherapy for Veteran Trauma Survivors.
International journal of environmental research and public health    October 13, 2025   Volume 22, Issue 10 1557 doi: 10.3390/ijerph22101557
Kowalski H, Van Buiten H, Hopkins P, Baldwin C, Nazarenko E, Marchand WR.The primary aim of this study was to evaluate the feasibility, safety, and preliminary outcomes of the Equine Assisted Growth and Learning Association (Eagala) model of equine-assisted psychotherapy for active-duty military and veteran trauma survivors. This was a retrospective multi-site observational study. Study participants completed four psychological instruments pre- and post-intervention. These were the PTSD Checklist for DSM-5, the Patient Health Questionnaire, the Satisfaction with Life Scale and the Sheehan Disability Scale. The Client Satisfaction Questionnaire-8 was also completed ...
Effects of the Sodium-Glucose Cotransporter-2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation.
Journal of veterinary internal medicine    October 9, 2025   Volume 39, Issue 6 e70256 doi: 10.1111/jvim.70256
Thane K, Voth R, Klee R, Warnken T, Chukwu V, Frank N.Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Objective: The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Methods: Privately-owned adult horses (n = 37) with laboratory-confirmed ID (low-dose oral sugar test insulin concentration > 75 μIU/mL). Methods: Double-blind randomized placebo-controlled trial. Horses received placebo (n = 19) or velagliflozin 0.3 mg/kg PO q24h (n = 18) for 20 weeks (Study Period 1, SP1) immediately followed by a 20-week ope...
Antimicrobial use in equine patients at a veterinary teaching hospital in the northeastern United States reveals opportunities for enhanced stewardship.
Journal of the American Veterinary Medical Association    October 8, 2025   Volume 264, Issue 2 1-8 doi: 10.2460/javma.25.06.0373
Velarde PS, Cummings KJ, LaPointe C, Perkins GA.To assess the use of systemic antimicrobial agents in equine patients and identify areas where their use could be reduced. Unassigned: A retrospective study evaluating the electronic medical records for all equine visits in which systemic antimicrobials were given at a veterinary teaching hospital for 1 year (2021). Negative binomial regression analysis was used to evaluate factors associated with antimicrobial prescription rate. Unassigned: Systemic antimicrobials were prescribed for 33.5% (543 of 1,622) of equine visits. For most visits (89.1%), ≤ 3 antimicrobials were given. The antimicro...
Treatment of luteal phase mares with the aromatase inhibitor letrozole does not change characteristics of the estrous cycle, ovarian function, and embryo characteristics.
Research in veterinary science    October 8, 2025   Volume 197 105935 doi: 10.1016/j.rvsc.2025.105935
Khan Y, Gautier C, Aurich C, El-Shalofy A.Letrozole is a potent and highly selective third-generation aromatase inhibitor. In the present study, we aimed to investigate the effects of letrozole treatment of non-pregnant mares on estrous cycle characteristics. Cyclic, non-lactating mares (n = 9) were included. After estrus synchronization, mares were monitored to detect ovulation (d0:) of the treatment cycle. Each three mares were randomly assigned to one of three treatments: control, 0.5, and 1 mg/kg body weight letrozole in three consecutive cycles (d7 to d13 of the treatment cycle). Mares were inseminated in the estrus after trea...
Complications in Theriogenology.
The Veterinary clinics of North America. Equine practice    October 7, 2025   Volume 41, Issue 3 579-594 doi: 10.1016/j.cveq.2025.08.007
Gomes VCL, Strachota JR.This article explores key complications in equine reproduction, focusing on their causes, diagnosis, treatment, and prevention. It emphasizes the risks associated with common procedures, particularly those that are iatrogenic, meaning caused by medical intervention. The discussion highlights how understanding these risks can help in early detection and management, ultimately improving reproductive success and animal welfare. The article also provides insights into best practices to minimize complications, ensuring safer procedures and better outcomes for breeding horses.
Adverse Effects of Antimicrobial Drugs Use in Horses.
The Veterinary clinics of North America. Equine practice    October 6, 2025   Volume 41, Issue 3 633-651 doi: 10.1016/j.cveq.2025.08.010
Gomez DE, Johnson JP.Antimicrobial drug therapy in horses can lead to adverse effects across multiple body systems, with specific age groups, such as foals, at particular risk. Certain antimicrobial drugs, such as penicillins, aminoglycosides, macrolides, tetracyclines, and trimethoprim-sulfonamide combinations, are commonly implicated. This review explores the mechanisms behind these adverse reactions, emphasizing the importance of judicious antimicrobial drug use. This review also underscores the need for a centralized pharmacovigilance system to improve drug safety and adverse event reporting for veterinary med...
Preanesthetic Administration of Trazodone Does Not Impact Anesthetic Recovery Scores in Horses.
Animals : an open access journal from MDPI    October 6, 2025   Volume 15, Issue 19 2907 doi: 10.3390/ani15192907
Joseph EJ, Love L, Mayakis M, Varner K.Trazodone is administered to hospitalized equine patients to aid in behavioral management, but the effects on the anesthetic recovery period have not been investigated. This study sought to determine if there is an association between trazodone administration and recovery quality, recovery time, need for sedation, or need for reversal agent administration. We hypothesized that there would be no difference in recovery scores, recovery time, additional sedation, or reversal agent administration between horses that received preanesthetic trazodone and horses that did not. Records were reviewed to...
Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction.
Animals : an open access journal from MDPI    October 5, 2025   Volume 15, Issue 19 2905 doi: 10.3390/ani15192905
Parmantier S, Kyriazopoulou P, McClendon M, Adams A, Murphy BA.Fifty-two horses aged >15 years, diagnosed with pituitary pars intermedia dysfunction (PPID), and displaying hypertrichosis were recruited via an online survey of PPID horse owners. From mid-December, group T ( = 29) wore Equilume light masks extending photoperiod to 15 h daily, while group C1 ( = 23) remained under natural photoperiod. As 85% (44/52) of recruited study horses received pergolide medication, a second unmedicated PPID research herd (C2; = 17) was recruited and remained under natural photoperiod. Hair coat samples, shedding and body condition scores were collected monthly by own...
In Vitro Effects of PRP, Ozonized PRP, Hyaluronic Acid, Paracetamol, and Polyacrylamide on Equine Synovial Fluid-Derived Mesenchymal Stem Cells.
Life (Basel, Switzerland)    October 4, 2025   Volume 15, Issue 10 1558 doi: 10.3390/life15101558
Bungărdean D, Pall E, Daradics Z, Popescu M, Tripon MA, Lupșan AF, Crecan CM, Morar IA, Nicolescu A, Bora FD, Marcus I.Musculoskeletal disorders are a major cause of lameness in horses, often necessitating innovative regenerative strategies to restore joint function and improve quality of life. This study investigated the effects of platelet-rich plasma (PRP), ozonized PRP, hyaluronic acid, paracetamol, and polyacrylamide hydrogel (NOLTREX) on the behavior of mesenchymal stem cells (MSCs) derived from equine synovial fluid. Synovial fluid samples were collected under strict cytological criteria to ensure viability, followed by in vitro expansion and phenotypic characterization of MSCs. Cultures were supplement...
Cytochrome c oxidase I deep amplicon sequencing for metabarcoding of equine strongyle communities: unexpectedly high Strongylus spp. prevalence in treated horses.
International journal for parasitology    October 4, 2025   S0020-7519(25)00182-1 doi: 10.1016/j.ijpara.2025.09.007
Krücken J, Diekmann I, Andreotti S, Bredtmann CM, Mbedi S, Sparmann S, Schmidt JS, de Almeida Borges F, de Freitas MG, Sallé G, Hofer H....Equines are parasitized by complex communities of Strongylidae (Nematoda) comprising multi-species infections. Currently, Cyathostominae are most prevalent, while Strongylus species are only rarely detected. Since eggs and, in most cases, infective larvae cannot be differentiated to species level, except for Strongylus spp., species-specific knowledge of the pathology, epidemiology and ecology of these parasitic nematodes is limited. Reference sequence data for several cyathostomin species are limited or missing. Deep amplicon sequencing of internal transcribed spacer 2 (ITS-2) regions of nema...
Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract. Beermann A, Hamza E, Reinhard S, Koch C, Oberhänsli T, Unger L.We investigated microRNAs (miRNAs) as potential prognostic biomarkers for equine sarcoid (ES) disease. In a breed-, age-, and sex-matched case-controlled study involving 45 ES-affected and 15 control horses, we assessed the diagnostic, prognostic, and theragnostic value of 3 miRNAs (eca-miR-127, eca-miR-379, eca-miR-432) in horses treated with European mistletoe () extract versus placebo. Whole-blood miRNA concentrations were measured using reverse-transcription quantitative real-time PCR (RT-qPCR) at 3 different times. We found that eca-miR-432 expression was lower in ES-affected (median =â...
Pharmacokinetics and preliminary safety of single-dose oral fluralaner at 10 and 25 mg/kg in healthy horses revealed no adverse reactions.
American journal of veterinary research    October 3, 2025   Volume 86, Issue 12 ajvr.25.06.0200.xml doi: 10.2460/ajvr.25.06.0200
Morgan JM, Gentille SR, Goyette FD, Lehman ML, Boss AL, Cassano JM, Knych HK, White SD.To determine the safety and pharmacokinetics of a single dose of the oral ectoparasiticide fluralaner at 10 and 25 mg/kg in healthy horses. Unassigned: 12 clinically healthy university-owned horses, 9 to 17 years of age, were administered a single oral dose of fluralaner at 10 or 25 mg/kg. Physical examinations, neurological examinations, plasma samples, hematology and biochemistry panels, and skin biopsies were collected throughout the 84-day trial period. Fluralaner concentrations were measured in plasma and skin by liquid chromatography-tandem mass spectrometry, and pharmacokinetics were ev...
A high proportion of bacterial isolates from septic neonatal foals in Ontario express multidrug resistance and low susceptibility to first-line antimicrobials.
Journal of the American Veterinary Medical Association    October 1, 2025   Volume 264, Issue 2 1-8 doi: 10.2460/javma.25.05.0339
Espinosa Seoane D, Riley CB, Kenney DG, Spencer A, Arroyo LG.To describe common bacterial isolates cultured from sick neonatal foals and their antimicrobial susceptibility and resistance patterns. Unassigned: Medical records of foals ≤ 30 days of age, admitted to the Ontario Veterinary College from 2020 to 2023, and with a positive aerobic bacterial culture and susceptibility testing performed (Kirby-Bauer method) were included. A descriptive analysis of species isolated and antimicrobial and multidrug resistance profiles was performed. Unassigned: 62 samples from 60 predominantly Thoroughbred (42% [25 of 60]) neonatal foals (median age, 8 days) yield...
Complications of the Recumbent Horse: Diagnosis and Management.
The Veterinary clinics of North America. Equine practice    September 30, 2025   Volume 41, Issue 3 619-632 doi: 10.1016/j.cveq.2025.08.009
Delvescovo B, Bouton J.This issue focuses on the potential complications caused by prolonged recumbency in horses. It discusses how managing a recumbent horse involves treating the primary illness while also preventing and addressing secondary issues that can arise from recumbency itself. The authors explore the underlying pathophysiology of these complications, along with strategies for prevention and treatment. By understanding these aspects, veterinarians can improve care and outcomes for horses that are immobilized for extended periods. The issue provides insights into the most common complications and emphasize...
A pilot study on the potency of injectable vs. oral moxidectin formulation to suppress strongyle egg excretion in horses at twice lower dose.
Helminthologia    September 30, 2025   Volume 62, Issue 2 87-94 doi: 10.2478/helm-2025-0018
Šarkūnas M, Schwahn A, Suleimanova K.The aim of present study was to examine the potency of moxidectin solution (Cydectin 1 %; Zoetis) and commercially available oral moxidectin gel (Equest®; Zoetis) to suppress the excretion of strongyle eggs in horses over a 6-week period. The horses naturally infected with strongyle nematodes (>500 eggs/g of feces) were divided into two comparable groups according age, sex and weight. On day 0 of the study, horses in Group OT (oral treatment; N=5) were dewormed with moxidectin gel (Equest®; Zoetis; 0.4 mg/kg of b.w.) according to the manufacturer's instructions, and horses in Group IT (intra...
Complications in Wound Management.
The Veterinary clinics of North America. Equine practice    September 30, 2025   Volume 41, Issue 3 563-578 doi: 10.1016/j.cveq.2025.08.006
Morales Yñiguez FJ, Leise BS.Over 25% of all emergencies are classified as wounds, making them the most common health conditions treated by veterinarians. While equine wounds may heal with minimal intervention, many complications associated with wound management can occur, thereby delaying wound healing and leading to chronic non-healing wounds. Wounds should be closed primarily when possible; however, numerous factors influence the risk of complications. Infection and biofilm production are common causes of delayed wound healing. Other causes of non-healing wounds include the presence of foreign material, sequestrum form...
BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology.
Viruses    September 29, 2025   Volume 17, Issue 10 1322 doi: 10.3390/v17101322
Monteiro MM, de Castro ELA, Pereira AJM, Thiesen R, Thiesen RMC, Salvarani FM.Equine sarcoids are the most common dermatological neoplasm in horses worldwide, associated with bovine papillomavirus (BPV) infection and characterized by high recurrence rates after conventional therapies. Bacillus Calmette-Guérin (BCG) immunotherapy has historically been used for sarcoid treatment, yet its role in contemporary veterinary oncology remains debated. This narrative review critically examines the immunological mechanisms, clinical efficacy, and limitations of BCG in equine sarcoid therapy, while integrating insights from comparative oncology and One Health perspectives. A syste...
Cervical epidural catheter for administration of detomidine and morphine in a model of carpal synovitis in the horse.
Veterinary surgery : VS    September 29, 2025   doi: 10.1111/vsu.70031
Edwards VL, Reed R, Perlini M, Moorman VJ.To determine the analgesic effects of detomidine and morphine administered by cervical epidural catheter (CEC) on a model of thoracic limb pain. Methods: Prospective, randomized, blinded crossover study. Methods: Five adult horses. Methods: Cervical epidural catheters were placed under ultrasound guidance, followed by induction of lipopolysaccharide (LPS)-mediated carpal synovitis. Horses received either saline or detomidine/morphine (DM; 10 μg/kg, 0.1 mg/kg, respectively) via CEC 4 h after synovitis. After a 7 day washout, synovitis was induced in the contralateral carpus, and the alternate ...
Differences in Plasma Exposure of Cannabidiol and Cannabidiolic Acid Following Oral Administration to Horses.
Journal of veterinary pharmacology and therapeutics    September 28, 2025   Volume 49, Issue 1 22-32 doi: 10.1111/jvp.70027
Ekstrand C, Michanek P, Hernlund E, Gehring R, Spjut K, Salomonsson M.There has been a growing interest in the use of cannabinoids in horses in recent years. Several studies have reported on the pharmacokinetics of cannabidiol (CBD) in horses. However, cannabidiolic acid (CBDA) has received less attention, despite limited evidence suggesting clinically beneficial effects in other species. Horses were administered 3 mg/kg of CBD, 3 mg/kg of CBDA, and a placebo per os in a crossover design, with a one-week washout period between treatments. Plasma and urine samples were collected and analyzed using ultra high-performance liquid chromatography coupled to tandem...
Accidents, Injuries, and Complications in Equine Sports Medicine Practice.
The Veterinary clinics of North America. Equine practice    September 26, 2025   Volume 41, Issue 3 529-543 doi: 10.1016/j.cveq.2025.08.001
Allen TS, Johnson S.The physical stresses on equine athletes are unique and differ across various disciplines. Recognizing these differences is essential for early detection of injuries and effective management of the competition horse's health. Equine sports medicine involves specific challenges and risks that can be reduced through proper care, careful attention to technique, and a deep understanding of the demands of each sport. Proper training, regular monitoring, and sport-specific expertise are crucial in preventing injuries and ensuring optimal performance. By focusing on these aspects, veterinarians and t...
Complications of Equine Musculoskeletal Surgery and Procedures.
The Veterinary clinics of North America. Equine practice    September 26, 2025   Volume 41, Issue 3 545-561 doi: 10.1016/j.cveq.2025.08.005
Nelson B.Complications of equine musculoskeletal procedures and surgery are an inevitable occurrence. This article summarizes complications principally encountered by primary equine veterinarians who perform and manage musculoskeletal procedures and surgeries. Topics discussed include complications of musculoskeletal diagnostic procedures, angular/flexural limb deformities, and muscle, tendon, and ligament surgery; surgery of the foot, orthopedic and arthroscopic surgery, and cast management. Each section lists complications encountered and includes diagnostic and treatment considerations. Awareness of...
Complications in the Critically Ill Equine Patient.
The Veterinary clinics of North America. Equine practice    September 26, 2025   Volume 41, Issue 3 595-618 doi: 10.1016/j.cveq.2025.08.008
Mazur SE, Toribio RE.Complications in critically ill equine patients are often related to the underlying disease process but can also be a consequence of diagnostic and therapeutic interventions. Complications can be specific to the affected organ or body system; however, in critically ill patients, they frequently affect the vasculature, acid-base, electrolyte, and fluid balance, energy homeostasis, and coagulation, with systemic consequences. Infrequent monitoring, late detection, failure to adapt therapies, hematologic and biochemical abnormalities, coagulopathies, and systemic inflammation can all contribute t...
Assessment of the antiparasitic effectiveness of pyrantel pamoate in treatment of Strongylidae invasions in young horses – preliminary studies.
Polish journal of veterinary sciences    September 25, 2025   Volume 28, Issue 3 441-448 doi: 10.24425/pjvs.2025.156069
Studzińska M, Klockiewicz M, Szczepaniak K, Demkowska-Kutrzepa M, Roczeń-Karczmarz M, Tomczuk K.The resistance of strongyles to pyrantel pamoate has been reported in publications worldwide. There is no data on its efficacy in horses in Poland. Therefore, the aim of this study was to evaluate the effectiveness of pyrantel pamoate to control strongyle invasions in young horses. The study involved horses of both sexes, aged 1 to 2 years, and was conducted in two seasons (spring and the end of summer). Feces were collected 24 hours before and 14 days after deworming, and they were then examined using McMaster's and combined sedimentation-flotation methods. Results revealed that in spring, th...
Adverse Effects and Drug Reactions in Equids.
The Veterinary clinics of North America. Equine practice    September 24, 2025   Volume 41, Issue 3 653-674 doi: 10.1016/j.cveq.2025.08.011
Wilson KE, Davis JL.Adverse drug events (ADEs) are any harms caused by medical interventions used for treatment, prevention, or diagnosis. These events can happen due to human error or as unintended, harmful reactions to drugs when given at normal therapeutic doses. This review focuses on common ADEs associated with drugs frequently used in equine practice. Recognizing and understanding the manifestations of ADEs can help with early detection and more effective management, ultimately leading to better outcomes for equine patients. Additionally, knowledge of the potential harmful effects of drugs also aids in appr...
Xenogen-free media provide variable equine mesenchymal stromal cell expansion after a 7-day culture period.
American journal of veterinary research    September 24, 2025   Volume 86, Issue 12 ajvr.25.03.0109.xml doi: 10.2460/ajvr.25.03.0109
Larson MK, Gaffney C, Hoagland C, Jayawickrama J, Kamm JL.To determine the xenogen-free serum source that provides the greatest number of live equine mesenchymal stromal cells (MSCs) while maintaining the MSC phenotype. Unassigned: Equine bone marrow-derived MSCs from 8 horses were cultured for 7 days in media containing one of the following serum treatments: 10% xenogeneic serum, 10% or 20% commercial allogeneic equine serum, 10% autologous serum, 10% equine pooled platelet lysate (PPL), or a staged media reduction of xenogeneic media. Live cell numbers, MSC viability, and MSC immunophenotype were compared. Unassigned: The use of 10% commercial allo...
Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma.
Veterinary ophthalmology    September 22, 2025   Volume 28, Issue 6 977-982 doi: 10.1111/vop.70086
Tucker-Retter EK, Yamagata M, Gilger B, Oh A.To assess whether topical carbonic anhydrase inhibitors (CAIs) with or without episcleral brinzolamide implants control intraocular pressure (IOP) in horses with glaucoma. Methods: 12 client-owned horses diagnosed with glaucoma. Methods: Medical records of horses treated with topical CAIs for ≥ 14 days, with a subset receiving episcleral brinzolamide implants, were reviewed. Diagnosis, signalment, concurrent ocular disease, medications, IOP, visual status, and additional procedures were recorded. Treatment failure was defined as horses with IOP > 30 mmHg resulting in phthisis bulbi o...
Differential effects of flunixin meglumine and meloxicam on TNF- α production in LPS-stimulated equine neutrophils in vitro.
Veterinary and animal science    September 21, 2025   Volume 30 100513 doi: 10.1016/j.vas.2025.100513
Urayama S, Muko R, Muranaka M, Mita H, Ohta M, Matsuda H, Tanaka A.Systemic inflammatory response syndrome (SIRS) induced by endotoxemia is usually secondary to colitis and is a major cause of high morbidity and mortality in horses. Non-steroidal anti-inflammatory drugs (NSAIDs), such as flunixin meglumine (FM) and meloxicam (MX), are used to improve clinical outcomes in SIRS/endotoxemia. These NSAIDs suppress tumor necrosis factor-alpha (TNF-α) levels; however, the underlying mechanisms remain unclear. The aim of this study was to investigate the inhibitory effects of FM and MX on TNF-α in lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear ce...
Retrospective performance-indexed analysis of Thoroughbred racehorses undergoing surgical management of proximal sesamoid bone fractures.
Equine veterinary journal    September 19, 2025   doi: 10.1111/evj.70102
Yeomans A, Cramp P, Carpenter R, Bladon B.Proximal sesamoid bone fractures (PSBFs) are a leading cause of economic losses. Post-operative racing prognosis is multi-factorial; however, recent studies are lacking. Objective: To provide an update on racing outcomes for horses undergoing surgical management of PSBFs, analyse variables affecting performance and compare post-operative racing performance with pre-operative data and case-matched controls. Methods: Retrospective case series. Methods: Thoroughbred racehorses that underwent PSBF repair (2008-2022) were included. Data retrieved included fracture type, limb, axiality, treatment, a...
1 3 4 5 6 7 95